Karuna Therapeutics (KRTX) Stock Analysis
DELISTED 2024
What happened to Karuna Therapeutics (KRTX) stock?
Karuna Therapeutics (KRTX) no longer trades on public markets. It was delisted in March 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2024
- Last recorded price (historical):
- $329.83 (last quote on record before the March 2024 delisting; historical, not a current quote)
Market cap $12.6B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Karuna Therapeutics (KRTX). Karuna Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative medicines for psychiatric and neurological conditions.
Last analyzed: May 10, 2026Karuna Therapeutics (KRTX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy KRTX shares?
No. KRTX stopped trading on public markets in March 2024, so the shares are not available through a broker. Anything you see quoted for KRTX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before KRTX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Karuna Therapeutics. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.